-
41
Developing anti-TDE vaccine for sensitizing cancer cells to treatment and metastasis control
Published 2025-01-01Get full text
Article -
42
Sculpting multi-epitope vaccine against Monkeypox viral strains using immunoinformatics
Published 2025-01-01Get full text
Article -
43
-
44
-
45
Global cervical cancer elimination: quantifying the status, progress, and gaps
Published 2025-02-01“…We summarised quantitative results concerning CC elimination across these countries, including the progress in implementing three prevention levels (human papillomavirus [HPV] vaccination, CC screening, and treatment for patients with CC) and achievement of interim Global Strategy for Cervical Cancer Elimination targets. …”
Get full text
Article -
46
Life Science 2.0: reframing the life science sector for ‘the benefit on mankind’
Published 2024-12-01“…The COVID-19 pandemic put the life science sector to the test. Vaccines were developed at unprecedented speed, benefiting from decades of fundamental research and now honoured by a Nobel Prize. …”
Get full text
Article -
47
Burden of pertussis in infants in the Eastern Mediterranean Region and the impact of maternal vaccination: a systematic review
Published 2025-01-01“…Abstract Background Despite vaccine availability, Pertussis remains a global public health challenge, especially among infants. …”
Get full text
Article -
48
-
49
-
50
Impact of Point-of-Care Testing on Diagnosis, Treatment, and Surveillance of Vaccine-Preventable Viral Infections
Published 2025-01-01“…However, breakthrough infections or uncovered strains can still cause vaccine-preventable viral infections (VPVIs). Therefore, timely diagnosis, treatment, and surveillance of these viruses is critical to patient care and public health. …”
Get full text
Article -
51
SARS-CoV-2 Evolution: Implications for Diagnosis, Treatment, Vaccine Effectiveness and Development
Published 2024-12-01“…The focus of this review is to provide a comprehensive analysis of the functional impact of mutations on diagnosis, treatments, and vaccine effectiveness. We further discuss vaccine safety in pregnancy and the implications of hybrid immunity on long-term protection against infection, as well as the latest developments on a pan-coronavirus vaccine and nasal formulations, emphasizing the need for continued surveillance, research, and adaptive public health strategies in response to the ongoing SARS-CoV-2 evolution race.…”
Get full text
Article -
52
-
53
In silico design of a multi-epitope vaccine against Mycobacterium avium subspecies paratuberculosis
Published 2025-01-01“…The widespread chronic enteritis known as Paratuberculosis (PTB) or Johne's disease (JD) is caused by Mycobacterium avium subspecies paratuberculosis (MAP), posing a significant threat to global public health. Given the challenges associated with PTB or JD, the development and application of vaccines are potentially important for disease control. …”
Get full text
Article -
54
-
55
-
56
SHASI-ML: a machine learning-based approach for immunogenicity prediction in Salmonella vaccine development
Published 2025-02-01“…IntroductionAccurate prediction of immunogenic proteins is crucial for vaccine development and understanding host-pathogen interactions in bacterial diseases, particularly for Salmonella infections which remain a significant global health challenge.MethodsWe developed SHASI-ML, a machine learning-based framework for predicting immunogenic proteins in Salmonella species. …”
Get full text
Article -
57
Global progress, challenges and strategies in eliminating public threat of viral hepatitis
Published 2025-02-01Get full text
Article -
58
-
59
Global insights into MRSA bacteremia: a bibliometric analysis and future outlook
Published 2025-01-01“…Additionally, artificial intelligence (AI) and machine learning are increasingly applied in MRSA diagnosis and treatment, and phage therapy and vaccine development have become future research hotspots.ConclusionMethicillin-resistant Staphylococcus aureus BSIs remain a major global public health challenge, especially with the increasing severity of antibiotic resistance. …”
Get full text
Article -
60